Bortezomib(Velcade®)-thalidomide-dexamethasone versus thalidomide-dexamethasone to treat multiple myeloma patients progressing or relapsing after autologous transplantation: the MMVAR trial

被引：0
|
作者：
Garderet, L.
Iacobelli, S.
Moreau, P.
Onida, F.
Koenecke, C.
Scheid, C.
Doyen, C.
Bouko, Y.
Ketterer, N.
Masszi, T.
Crawley, C.
Hajek, R.
Linkesch, W.
Ludwig, H.
Harousseau, J. L.
Michallet, M.
de Witte, T.
Niederwieser, D.
Gahrton, G.
Morris, T. C. M.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [1] Bortezomib (Velcade)-thalidomide-dexamethasone is superior to thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation
    Garderet, L.
    Iacobelli, S.
    Moreau, P.
    Dib, M.
    Caillot, D.
    Niederwieser, D.
    Masszi, T.
    Fontan, J.
    Michallet, M.
    Gratwohl, A.
    Milone, G.
    Doyen, C.
    Pegourie, B.
    Hajek, R.
    Casassus, P.
    Kolb, B.
    Chaleteix, C.
    Hertenstein, B.
    Onida, F.
    Ludwig, H.
    Vekemans, M. C.
    Ketterer, N.
    Daguenel, A.
    Koenecke, C.
    Gorin, N. -C.
    Harousseau, J. -L.
    de Witte, T.
    Morris, C.
    Gahrton, G.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S3 - S3
  • [2] Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation.
    Garderet, Laurent
    Iacobelli, Simona
    Moreau, Philippe
    Dib, Mamoun
    Caillot, Denis
    Niederwieser, Dietger W.
    Masszi, Tamas
    Fontan, Jean
    Michallet, Mauricette
    Gratwohl, Alois
    Milone, Giuseppe
    Doyen, Chantal
    Pegourie, Brigitte
    Hajek, Roman
    Casassus, Philippe
    Kolb, Brigitte
    Chaleteix, Carine
    Hertenstein, Bernd
    Onida, Francesco
    Ludwig, Heinz
    Vekemans, Marie Christiane
    Ketterer, Nicolas
    Daguenel, Anne
    Gorin, Norbert C.
    Harousseau, Jean Luc
    de Witte, Theo
    Morris, Curly
    Gahrton, Gosta
    [J]. BLOOD, 2010, 116 (21) : 1254 - 1254
  • [3] Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) versus Thalidomide-Dexamethasone to treat multiple myeloma (MM) patients progressing or relapsing after autologous transplantation: the MMVAR trial, a study from the myeloma subcommittee of the Chronic Leukemia Working Party of the EBMT
    Garderet, L.
    Iacobelli, S.
    Moreau, P.
    Onida, F.
    Koenecke, C.
    Pabst, T.
    Doyen, C.
    Crawley, C.
    Hajek, R.
    Linkesch, W.
    Harousseau, J. L.
    Michallet, M.
    Doran, Z.
    de Witte, T.
    Niederwieser, D.
    Gahrton, G.
    Morris, C.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S30 - S30
  • [4] Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone to treat multiple myeloma patients progressing or relapsing after autologous transplantation:: the MMVAR trial, a study from the myeloma subcommittee of the Chronic Leukemia Working Party of the EBMT
    Garderet, L.
    Iacobelli, S.
    Moreau, P.
    Onida, F.
    Koenecke, C.
    Pabst, T.
    Doyen, C.
    Crawley, C.
    Hajek, R.
    Linkesch, W.
    Harousseau, J. -L.
    Michallet, M.
    Doran, Z.
    de Witte, T.
    Niederwieser, D.
    Gahrton, G.
    Morris, C.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S36 - S36
  • [5] Bortezomib (velcade(R))-thalidomide-dexamethasone (VTD) vs thalidomide-dexamethasone (TD) in preparation for autologous stem-cell (SC) transplantation (ASCT) in newly diagnosed multiple myeloma (MM)
    Cavo, Michele
    Patriarca, Francesca
    Tacchetti, Paola
    Galli, Monica
    Perrone, Giulia
    Petrucci, Maria Teresa
    Brioli, Annamaria
    Bringhen, Sara
    Pantani, Lucia
    Tosi, Patrizia
    Crippa, Claudia
    Zamagni, Elena
    Di Raimondo, Francesco
    Narni, Franco
    Cellini, Claudia
    Ceecolini, Michela
    Pescosta, Norbert
    Goldaniga, Maria Cecilia
    Montefusco, Vittorio
    Callea, Vincenzo
    De Stefano, Valerio
    Caravita, Tommaso
    Boccadoro, Mario
    Baccarani, Michele
    [J]. BLOOD, 2007, 110 (11) : 30A - 30A
  • [6] Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma
    Wang, M.
    Giralt, S.
    Delasalle, K.
    Handy, B.
    Alexanian, R.
    [J]. HEMATOLOGY, 2007, 12 (03) : 235 - 239
  • [7] Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
    Cavo, Michele
    Pantani, Lucia
    Petrucci, Maria Teresa
    Patriarca, Francesca
    Zamagni, Elena
    Donnarumma, Daniela
    Crippa, Claudia
    Boccadoro, Mario
    Perrone, Giulia
    Falcone, Antonietta
    Nozzoli, Chiara
    Zambello, Renato
    Masini, Luciano
    Furlan, Anna
    Brioli, Annamaria
    Derudas, Daniele
    Ballanti, Stelvio
    Dessanti, Maria Laura
    De Stefano, Valerio
    Carella, Angelo Michele
    Marcatti, Magda
    Nozza, Andrea
    Ferrara, Felicetto
    Callea, Vincenzo
    Califano, Catello
    Pezzi, Annalisa
    Baraldi, Anna
    Grasso, Mariella
    Musto, Pellegrino
    Palumbo, Antonio
    [J]. BLOOD, 2012, 120 (01) : 9 - 19
  • [8] BORTEZOMIB PLUS DEXAMETHASONE VERSUS REDUCED-DOSE BORTEZOMIB PLUS THALIDOMIDE-DEXAMETHASONE AS INDUCTION PRIOR TO AUTOLOGOUS TRANSPLANTATION IN NEWLY DIAGNOSED MYELOMA
    Harousseau, J. L.
    Avet-Loiseau, H.
    Mary, J.
    Facon, T.
    Attal, M.
    Doyen, C.
    Hulin, C.
    Garderet, L.
    Tiab, M.
    Lepeu, G.
    Araujo, C.
    Caillot, D.
    Petillon, M.
    Mathiot, C.
    Moreau, P.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 451 - 451
  • [9] Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma
    Wang, M
    Weber, DM
    Delasalle, K
    Alexanian, R
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2005, 79 (03) : 194 - 197
  • [10] Molecular Remission After Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Consolidation Therapy Following Double Autologous Transplantation for Multiple Myeloma: Results of a Qualitative and Quantitative Analysis
    Terragna, Carolina
    Zamagni, Elena
    Petrucci, Maria Teresa
    Durante, Sandra
    Patriarca, Francesca
    Narni, Franco
    Crippa, Claudia
    Gorgone, Ausilia
    Caravita, Tommaso
    Perrone, Giulia
    Nozzoli, Chiara
    Masini, Luciano
    Callea, Vincenzo
    Attolico, Immacolata
    Cellini, Claudia
    Bringhen, Sara
    Ledda, Antonio
    Montefusco, Vittorio
    Martello, Marina
    Martinelli, Giovanni
    Baccarani, Michele
    Cavo, Michele
    [J]. BLOOD, 2010, 116 (21) : 376 - 376
12345